$AMRH reverse merger partner Jay Pharma has Israeli adcom recommendation for phase 1/2 study of it's CBD brain cancer candidate. 

#stocks #stockstowatch #StockTrading #StocksToTrade #stockMarket    super- #Lowfloat #lowfloater